The Georgia/South Carolina Region of The Leukemia & Lymphoma Society (LLS), a global leader in the fight against cancer, has announced that BlueCross BlueShield of South Carolina has joined Columbia’s 2022 Light The Night® campaign as Presenting Sponsor. Light The Night, an annual fundraising event that aims to create a world without blood cancer, will take place on Thursday, November 3, 2022 at the South Carolina State House.
Culminating in evening events this fall, communities across North America will join together at Light The Night carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters, and gold in memory of loved ones lost to cancer.
The funds raised through Light The Night are used to support LLS’s mission priorities: Research, Education & Support and Policy & Advocacy. Through campaigns like Light The Night, LLS has invested more than $1.5 billion since its inception in research to advance breakthrough therapies.
“We’re thrilled to have BlueCross as Presenting Sponsor of this year’s Light The Night in Columbia,” said, Amanda Yancey Executive Director at The Leukemia & Lymphoma Society’s Georgia-South Carolina Region. “The Leukemia & Lymphoma Society generates and delivers hope in a time of despair, a community in place of loneliness and lifesaving research and support for cancer patients and their families. Now is the time for us to be bigger and more powerful than we’ve ever been before.”
Despite the progress, more than a third of blood cancer patients still do not survive five years after their diagnosis.
We invite you to join us for this family-friendly community event as we gather together to celebrate survivors and fight blood cancer on Thursday, November 3rd at the South Carolina State House.
Blood cancer patients and their families can contact the LLS Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is a global leader in the fight against cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, LLS has regional offices throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the LLS Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.
For additional information visit lls.org/lls-newsnetwork.